<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oral Cancer News &#187; Archive</title>
	<atom:link href="http://oralcancernews.org/wp/category/oral_cancer_news/oral-cancer-news-archive/feed/" rel="self" type="application/rss+xml" />
	<link>http://oralcancernews.org/wp</link>
	<description>The Oral Cancer Foundation News Archive</description>
	<lastBuildDate>Wed, 08 Feb 2012 03:51:57 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Risky HPV detected in human breast milk</title>
		<link>http://oralcancernews.org/wp/risky-hpv-detected-in-human-breast-milk/</link>
		<comments>http://oralcancernews.org/wp/risky-hpv-detected-in-human-breast-milk/#comments</comments>
		<pubDate>Sat, 05 Jul 2008 20:29:14 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5751</guid>
		<description><![CDATA[7/5/2008 New York, NY Karla Gale Reuters (www.reuters.com) Human papillomavirus type 16 (HPV-16), which has been linked to cervical cancer, can be detected in human breast milk collected during the early period after a woman delivers her baby, doctors from Finland report. It is possible that HPV DNA present in breast milk may be transmitted [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/risky-hpv-detected-in-human-breast-milk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Advexin moves closer to market</title>
		<link>http://oralcancernews.org/wp/advexin-moves-closer-to-market/</link>
		<comments>http://oralcancernews.org/wp/advexin-moves-closer-to-market/#comments</comments>
		<pubDate>Fri, 04 Jul 2008 20:28:55 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5749</guid>
		<description><![CDATA[7/4/2008 web-based article Matthew Dennis cancerdrugnewsblog.blogspot.com Introgen Therapeutics has submitted a BLA to the FDA, while simultaneously Gendux Molecular (Introgen) has submitted an MAA to the EMEA, both seeking marketing approval for Advexin (INGN 201), the company&#8217;s targeted p53 tumour suppressor gene therapy, to treat recurrent, refractory head and neck cancer. INGN 201 represents the [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/advexin-moves-closer-to-market/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Impact of graphic anti-smoking photos burning out</title>
		<link>http://oralcancernews.org/wp/impact-of-graphic-anti-smoking-photos-burning-out-2/</link>
		<comments>http://oralcancernews.org/wp/impact-of-graphic-anti-smoking-photos-burning-out-2/#comments</comments>
		<pubDate>Fri, 04 Jul 2008 20:28:31 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5747</guid>
		<description><![CDATA[7/4/2008 Ottawa, Ontario, Canada Sarah Schmidt Canada.com Graphic health warnings on cigarette packages are failing to move the majority of smokers to quit, a new government survey has found. Over the last five years, the percentage of smokers who say the warnings are ineffective at getting them to try to kick the habit has increased, [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/impact-of-graphic-anti-smoking-photos-burning-out-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Seven Major U.S. Cancer Institutions Order Hyperthermia Systems from BSD Medical</title>
		<link>http://oralcancernews.org/wp/seven-major-us-cancer-institutions-order-hyperthermia-systems-from-bsd-medical/</link>
		<comments>http://oralcancernews.org/wp/seven-major-us-cancer-institutions-order-hyperthermia-systems-from-bsd-medical/#comments</comments>
		<pubDate>Thu, 03 Jul 2008 20:28:04 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5745</guid>
		<description><![CDATA[7/3/2008 Salt Lake City, UT press release The Earth Times (www.earthtimes.com) BSD Medical Corp. today announced the addition of seven new BSD-500 hyperthermia systems purchased by major cancer treatment center in the United States. The most recent purchase by the Massey Cancer Center at Virginia Commonwealth University located in Richmond, Virginia joins in a number [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/seven-major-us-cancer-institutions-order-hyperthermia-systems-from-bsd-medical/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>GSK Does Not Expect FDA Approval Of HPV Vaccine Cervarix Until End Of 2009</title>
		<link>http://oralcancernews.org/wp/gsk-does-not-expect-fda-approval-of-hpv-vaccine-cervarix-until-end-of-2009/</link>
		<comments>http://oralcancernews.org/wp/gsk-does-not-expect-fda-approval-of-hpv-vaccine-cervarix-until-end-of-2009/#comments</comments>
		<pubDate>Thu, 03 Jul 2008 20:27:41 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5743</guid>
		<description><![CDATA[7/3/2008 web-based article staff MedicalNewsToday.com GlaxoSmithKline on Monday said it does not expect to receive FDA approval for its human papillomavirus vaccine Cervarix until late 2009, Reuters reports. GSK said it has decided to wait until results from a Phase III trial of the vaccine are available before seeking U.S. approval. The study results likely [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/gsk-does-not-expect-fda-approval-of-hpv-vaccine-cervarix-until-end-of-2009/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Laser Surgery Probe Targets Individual Cancer Cells</title>
		<link>http://oralcancernews.org/wp/laser-surgery-probe-targets-individual-cancer-cells/</link>
		<comments>http://oralcancernews.org/wp/laser-surgery-probe-targets-individual-cancer-cells/#comments</comments>
		<pubDate>Tue, 01 Jul 2008 20:27:16 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5741</guid>
		<description><![CDATA[7/1/2008 Austin, TX staff Biocompare (news.biocompare.com) Mechanical engineering Assistant Professor Adela Ben-Yakar at The University of Texas at Austin has developed a laser &#8220;microscalpel&#8221; that destroys a single cell while leaving nearby cells intact, which could improve the precision of surgeries for cancer, epilepsy and other diseases. &#8220;You can remove a cell with high precision [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/laser-surgery-probe-targets-individual-cancer-cells/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Quit smoking with a proven approach</title>
		<link>http://oralcancernews.org/wp/quit-smoking-with-a-proven-approach/</link>
		<comments>http://oralcancernews.org/wp/quit-smoking-with-a-proven-approach/#comments</comments>
		<pubDate>Tue, 01 Jul 2008 20:26:56 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5739</guid>
		<description><![CDATA[7/1/2008 Chicago, IL D. Robert McCaffree, MD Chicago Tribune (www.chicagotribune.com) I read with interest the open letter from Dr. Brad Rodu to Sen. Obama in the June 22 Perspective section (&#8220;Quitting ins&#8217;t that easy&#8221;). In this open letter, Dr.Rodu advocated the use of smokeless and spit tobacco (which I will refer to only as spit [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/quit-smoking-with-a-proven-approach/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Clay S. Felker, 82 &#8211; Influential Editor of New York Magazine</title>
		<link>http://oralcancernews.org/wp/clay-s-felker-82-influential-editor-of-new-york-magazine/</link>
		<comments>http://oralcancernews.org/wp/clay-s-felker-82-influential-editor-of-new-york-magazine/#comments</comments>
		<pubDate>Tue, 01 Jul 2008 20:26:14 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5737</guid>
		<description><![CDATA[7/1/2008 Washingon, D.C. Matt Schudel Washington Post (www.washingpost.com) Clay S. Felker, the pioneering editor who founded New York magazine and helped launch the new journalism of the 1960s, with its novelistic techniques and strong point of view, died July 1 at his Manhattan home at 82. He had battled throat cancer in recent years. &#8220;He [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/clay-s-felker-82-influential-editor-of-new-york-magazine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Leading Medical Teams Rely on SensAble 3D Modeling System to Speed Cranial and Maxillofacial Reconstruction</title>
		<link>http://oralcancernews.org/wp/leading-medical-teams-rely-on-sensable-3d-modeling-system-to-speed-cranial-and-maxillofacial-reconstruction/</link>
		<comments>http://oralcancernews.org/wp/leading-medical-teams-rely-on-sensable-3d-modeling-system-to-speed-cranial-and-maxillofacial-reconstruction/#comments</comments>
		<pubDate>Mon, 30 Jun 2008 20:25:49 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5735</guid>
		<description><![CDATA[6/30/2008 Cardiff, Wales press release www.foxbusiness.com At the third annual conference on Advanced Digital Technology for Head and Neck Reconstruction today, SensAble Technologies, Inc, a leading provider of touch-enabled modeling solutions and haptic devices, and Majenta Solutions, an Authorized Reseller in the UK, showcased innovative uses of the FreeForm 3D modeling system for quickly creating [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/leading-medical-teams-rely-on-sensable-3d-modeling-system-to-speed-cranial-and-maxillofacial-reconstruction/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Face transplant pioneer in Cardiff</title>
		<link>http://oralcancernews.org/wp/face-transplant-pioneer-in-cardiff/</link>
		<comments>http://oralcancernews.org/wp/face-transplant-pioneer-in-cardiff/#comments</comments>
		<pubDate>Mon, 30 Jun 2008 20:25:22 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5733</guid>
		<description><![CDATA[6/30/2008 Cardiff, Wales Madeleine Brindley Wales Online (www.walesonline.co.uk) THE leader of the team which carried out the world’s first face transplant will lecture at a major international medical conference to be held in Cardiff. Professor Bernard Devauchelle, from Amiens, France, made international headlines in 2005 when his team carried out the world’s first face transplant [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/face-transplant-pioneer-in-cardiff/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Individualized Treatment Selection in Patients With Head and Neck Cancer &#8211; Do Molecular Markers Meet the Challenge?</title>
		<link>http://oralcancernews.org/wp/individualized-treatment-selection-in-patients-with-head-and-neck-cancer-do-molecular-markers-meet-the-challenge/</link>
		<comments>http://oralcancernews.org/wp/individualized-treatment-selection-in-patients-with-head-and-neck-cancer-do-molecular-markers-meet-the-challenge/#comments</comments>
		<pubDate>Mon, 30 Jun 2008 20:24:54 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5731</guid>
		<description><![CDATA[6/30/2008 web-based article Bhuvanesh Singh and David G. Pfister Journal of Clinical Oncology, Vol 26, No 19 (July 1), 2008: pp. 3114-3116 Integrated chemotherapy and radiation therapy have become the standard of care for most patients with advanced stage laryngopharyngeal cancers. The concurrent administration of these two modalities is the approach recommended by most experts [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/individualized-treatment-selection-in-patients-with-head-and-neck-cancer-do-molecular-markers-meet-the-challenge/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Knowledge and opinions regarding oral cancer among Maryland dental students</title>
		<link>http://oralcancernews.org/wp/knowledge-and-opinions-regarding-oral-cancer-among-maryland-dental-students/</link>
		<comments>http://oralcancernews.org/wp/knowledge-and-opinions-regarding-oral-cancer-among-maryland-dental-students/#comments</comments>
		<pubDate>Mon, 30 Jun 2008 20:24:32 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5729</guid>
		<description><![CDATA[6/30/2008 Bethesda, MD S Boroumand et al. J Cancer Educ, June 1, 2008; 23(2): 85-91 Background: Most oral cancers are diagnosed at late stages. Health care providers, particularly dentists, play a critical role in early detection of oral cancers and should be knowledgeable and skillful in oral cancer diagnosis. In this study, we assessed knowledge [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/knowledge-and-opinions-regarding-oral-cancer-among-maryland-dental-students/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prognostic factors of survival in head and neck cancer patients treated with surgery and postoperative radiation therapy</title>
		<link>http://oralcancernews.org/wp/prognostic-factors-of-survival-in-head-and-neck-cancer-patients-treated-with-surgery-and-postoperative-radiation-therapy/</link>
		<comments>http://oralcancernews.org/wp/prognostic-factors-of-survival-in-head-and-neck-cancer-patients-treated-with-surgery-and-postoperative-radiation-therapy/#comments</comments>
		<pubDate>Mon, 30 Jun 2008 20:24:09 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5727</guid>
		<description><![CDATA[6/30/2008 Clichy, France C Le Tourneau et al. Acta Otolaryngol, June 1, 2008; 128(6): 706-12 Conclusions: Given that radiation therapy (RT) is currently initiated as soon as possible after surgery, our results indicate that the main prognostic factors of survival are pT and pN stages in patients treated with surgery and postoperative RT for locally [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/prognostic-factors-of-survival-in-head-and-neck-cancer-patients-treated-with-surgery-and-postoperative-radiation-therapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Chemoselection As a Strategy for Organ Preservation in Advanced Oropharynx Cancer</title>
		<link>http://oralcancernews.org/wp/chemoselection-as-a-strategy-for-organ-preservation-in-advanced-oropharynx-cancer/</link>
		<comments>http://oralcancernews.org/wp/chemoselection-as-a-strategy-for-organ-preservation-in-advanced-oropharynx-cancer/#comments</comments>
		<pubDate>Mon, 30 Jun 2008 20:23:48 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5725</guid>
		<description><![CDATA[6/30/2008 Ann Arbor, MI Francis P. Worden et al. Journal of Clinical Oncology, Vol 26, No 19 (July 1), 2008: pp. 3138-3146 Response and Survival Positively Associated With HPV16 Copy Number Purpose: To test induction chemotherapy (IC) followed by concurrent chemoradiotherapy (CRT) or surgery/radiotherapy (RT) for advanced oropharyngeal cancer and to assess the effect of [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/chemoselection-as-a-strategy-for-organ-preservation-in-advanced-oropharynx-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genetically engineered viruses battle cancer</title>
		<link>http://oralcancernews.org/wp/genetically-engineered-viruses-battle-cancer/</link>
		<comments>http://oralcancernews.org/wp/genetically-engineered-viruses-battle-cancer/#comments</comments>
		<pubDate>Sun, 29 Jun 2008 20:23:15 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5723</guid>
		<description><![CDATA[6/29/2008 Washington, DC Robert Boyd origin.montereyherald.com Viruses aren&#8217;t always the bad guys. Sure, they can cause colds, measles, AIDS and other miseries. But with some tinkering, these tiny organisms may become a new and better way to treat cancer. In the last few years, scientists have been genetically engineering various viruses so they attack cancer [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/genetically-engineered-viruses-battle-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

